- No file added yet -
Multicentre study of the treatment of primary liver cancer in Africa with two anthracycline drugs
journal contribution
posted on 2024-09-06, 06:24 authored by C.F. Kiire, C. Gombe-Mbalawa, E. Tsega, J. Luande, L.V. Menenses, J. Okoth, C.L.M. Olweny, J. HollandHepatocellular carcinoma (HCC) is among the twelve commonest cancers affecting mankind. In tropical Africa HCC is the most common malignant tumor, particularly among men. In Kyadondo County of Uganda the incidence rate is 5,1 cases per 100 000 men. In Nigeria the figure quoted for both sexes is 5,9 per 100 000 population. In Zimbabwe the incidence among the Black population is 20,8 per 100 000, while in Mozambique the figure is 103,8 per 100 000 males. These figures are in contradiction to what is observed in Europe and North America. In England HCC occurs in 2,5 per 100 000, while in North America it is seen in 1,8 per 100 000.
A study of the treatment of primary liver cancer in tropical Africa.
A study of the treatment of primary liver cancer in tropical Africa.
History
Publisher
Faculty of Medicine, Central African Journal of Medicine (CAJM), University College of Rhodesia (now University of Zimbabwe)Citation
Kiire, C.F. et al., (1992) Multicentre study of the treatment of primary liver cancer in Africa with two anthracycline drugs, Central African Journal of Medicine, vol. 38, no. 11, pp. 428-431. Harare: CAJM.IDS Item Types
ArticleCopyright holder
University of Zimbabwe (UZ), Faculty of Medicine.Country
Africa.Language
enIdentifier ISSN
0008-9176Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC